SuperGen sells drugs for $1.2 million |
|
|
|
Published
:
Fri, 20 Apr 2007 16:09
|
DUBLIN, Calif. (AP) - Pharmaceutical company SuperGen Inc. said Friday it will the rights to anticancer agents mitomycin and paclitaxel to Intas Pharmaceuticals Ltd. for $1.2 million.SuperGen will receive $600,000 shortly after signing, with the balance due with product transfer later in the quarter, SuperGen said.Shares of SuperGen rose 16 cents, or 2.4 percent, to $6.83 on the Nasdaq Stock Market in morning trading. The stock has traded between $3.01 and $7.53 over the last 52 weeks.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
Print this Story
Zentiva buys stake in generics business 